QUINOLINE DERIVATIVES AS TYPE IV PHOSPHODIESTERASE INHIBITORS - Patent 0873338

(19)

(11)

EP 0 873 338 A1

(12)

(43)	Date of publication:
	28.10.1998 Bulletin 1998/44

(21)	Application number: 96938196.0

(22)	Date of filing: 13.11.1996

(51)

International Patent Classification (IPC):

C07D 401/ 04^{( . )}
A61K 31/ 47^{( . )}
A61P 11/ 00^{( . )}
A61P 25/ 16^{( . )}
A61P 25/ 28^{( . )}
A61P 37/ 00^{( . )}
C07D 401/ 14^{( . )}
C07D 413/ 14^{( . )}
C07D 417/ 14^{( . )}

A61K 31/ 00^{( . )}
A61K 31/ 4709^{( . )}
A61P 25/ 08^{( . )}
A61P 25/ 24^{( . )}
A61P 29/ 00^{( . )}
A61P 43/ 00^{( . )}
C07D 413/ 04^{( . )}
C07D 417/ 04^{( . )}

(86)	International application number:
	PCT/EP1996/004978

(87)	International publication number:
	WO 1997/018208 (22.05.1997 Gazette 1997/22)

(84)	Designated Contracting States:
	AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
	Designated Extension States:
	SI

(30)

Priority:

14.11.1995 GB 19950023267

(71)	Applicants:
	Novartis AG 4058 Basel (CH) Novartis-Erfindungen Verwaltungsgesellschaft m.b.H. 1230 Wien (AT)

(72)	Inventors:
	LÜÖND, Rainer CH-3098 Köniz (CH) POMBO VILLAR, Esteban CH-4056 Basle (CH)

(74)	Representative: Becker, Konrad, et al
	Novartis AG Geistiges Eigentum Konzern Patent- und Markenabteilung CH Postfach 4002 Basel 4002 Basel (CH)

(54)	QUINOLINE DERIVATIVES AS TYPE IV PHOSPHODIESTERASE INHIBITORS